<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">APAP treatment resulted in a significant elevation of HO-1 level compared to that in the control group (33.87 ± 5.15 pg/μg, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>g and Supplementary data 1, 
 <italic>P</italic> &lt; 0.01). HO-1 level was increasedin the silymarin + APAP (45.85 ± 5.10 pg/μg), GMSYS 700 + APAP (42.98 ± 5.39 pg/μg), and GMSYS 1400 + APAP (54.37 ± 8.35 pg/μg) groups compared to that in the APAP group, but not significantly.
</p>
